Search
for
Sort by
Research 391–420 of 1000+
- Tofacitinib: The selected selective JAK inhibitor in paediatric dermatology
- TYK2 Inhibition with Deucravacitinib Improves Clinical Outcomes and Resolves Interferon-Driven Inflammation in Lichen Planopilaris
- Case Report: Multimodal contact immunotherapy in alopecia areata: long-term clinical experience in the JAK inhibitor era
- Efficacy of topical tofacitinib in promoting hair growth in non-scarring alopecia: possible mechanism via VEGF induction
- New small molecules in dermatology: for the autoimmunity, inflammation and beyond
- Small Molecule Inhibitors and Inflammatory Skin Diseases
- Integrated safety analysis of baricitinib in adults with severe alopecia areata from two randomized clinical trials
- Ottawa, Ontario, Canada, February 13–16, 2013
- Role of topical tofacitinib in autoimmune skin disorders: An expert opinion
- Upadacitinib in dermatologic therapy: Emerging evidence and expanding indications
- Significant improvement with ivarmacitinib after suboptimal response to tofacitinib in severe alopecia areata: a case report and literature review
- Baricitinib for the Treatment of Moderate-to-Severe Alopecia Areata
- Hair follicle stem cells and the collapse of self-tolerance in alopecia: the interplay of barrier function, the microbiome, and immunity
- Tofacitinib therapy for children with severe alopecia areata
- A Cost-per-Responder Analysis of Ritlecitinib vs Baricitinib in Severe Alopecia Areata
- Response to tofacitinib therapy of eyebrows and eyelashes in alopecia areata
- Combination Therapy with Baricitinib and Narrowband Ultraviolet B for Active Non-Segmental Vitiligo: A Retrospective Controlled Study
- Appearance of alopecia areata during treatment with tildrakizumab for severe palmoplantar psoriasis
- Successful treatment with upadacitinib in concurrent atopic dermatitis, Crohn’s disease, alopecia areata, and eosinophilic gastropathy in a pediatric patient
- Learning from nudity: lessons from the nude phenotype
- An Open-Label Pilot Study to Evaluate the Efficacy of Tofacitinib in Moderate to Severe Patch-Type Alopecia Areata, Totalis, and Universalis
- Upadacitinib in the treatment of a patient with the triad of atopic dermatitis, vitiligo, and alopecia areata: a case report and literature review
- Alopecia areata
- Impacto del desequilibrio del microbioma del cuero cabelludo en la severidad de la alopecia areata, marcadores inflamatorios y cambios post-tratamiento
- 681 Inhibition of STAT3, using Oenocarpus bataua vegetable oil, on in vitro model
- 0433 JAK inhibitor halts the progression of acute exacerbation of alopecia areata
- Selective inhibition of JAK3 signaling is sufficient to reverse alopecia areata
- 153 Effectiveness of OR-101, a next generation highly selective JAK3 inhibitor, in a humanized murine model of alopecia areata
- Tyrosine Kinases in Autoimmune and Inflammatory Skin Diseases
- Induction of T cell exhaustion by JAK1/3 inhibition in the treatment of alopecia areata